United Therapeutics (UTHR) Jumps: Stock Adds 8.1% in Session
United Therapeutics Corporation (UTHR) was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $88.49 to $93.78 over the past one-month time frame.
None of the estimates for this med-drugs stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
United Therapeutics Corporation sports a Zacks Rank #1 (Strong Buy), while its Earnings ESP is 0.00%.
Investors interested in the industry may also consider stocks like Salix Pharmaceuticals Ltd. (SLXP), BioCryst Pharmaceuticals, Inc. (BCRX) and Durata Therapeutics, Inc. (DRTX). While Salix Pharmaceuticals sports a Zacks Rank #1, BioCryst Pharmaceuticals and Durata Therapeutics hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
UNITED THERAPEUTICS CP (UTHR): Free Stock Analysis Report
SALIX PHARMACEUTICALS LTD (SLXP): Free Stock Analysis Report
BIOCRYST PHARMACEUTICALS INC (BCRX): Free Stock Analysis Report
DURATA THERAPEUTICS INC (DRTX): Free Stock Analysis Report
Zacks Investment Research